Sai-Hong Ignatius Ou

Advanced search ?

Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.

Publisher

* You can search a publisher or tap the name directly

Subject Area

* You can search a subject area or tap the name directly

Open Acess

Yes

Quartille

Q1
Q3

Q2
Q4

You can also search
by the journal's Country or the impact indicator H-index.

Countries

* You can search a country or tap the name directly

H-Index

* You can also filter by Journal H-index

17 Publications

Publication								Year
Overcoming Central β-Sheet #6 (Cβ6) ALK Mutation (L1256F), TP53 Mutations and Short Forms of EML4-ALK v3/b and v5a/b Splice Variants are the Unmet Need That a Re-Imagined 5th-Generation (5G) ALK TKI Must Deliver Authors : Alexandria Lee , Sai-Hong Ignatius Ou Journal : Lung Cancer: Targets and Therapy Journal Reference count : 36 Volume : Volume 15 Pages : 19-27								2024
CROWN 2022 Second Interim Updates: When Will Be the Coronation of Lorlatinib? Authors : Misako Nagasaka , Sai-Hong Ignatius Ou Journal : Journal of Thoracic Oncology Journal Reference count : 22 Volume : 18 Pages : 139-142								2023
In Response to Continuation of Lorlatinib Beyond Progressive Disease Authors : Sai-Hong Ignatius Ou Journal : Journal of Thoracic Oncology Journal Reference count : 3 Volume : 17 Pages : e86-e88								2022
Lorlatinib Should Be Considered as the Preferred First-Line Option in Patients With Advanced ALK-Rearranged NSCLC Authors : Misako Nagasaka , Sai-Hong Ignatius Ou Journal : Journal of Thoracic Oncology Journal Reference count : 53 Volume : 16 Pages : 532-536								2021
A Catalog of 5’ Fusion Partners in ROS1-Positive NSCLC Circa 2020 Authors : Sai-Hong Ignatius Ou , Misako Nagasaka Journal : JTO Clinical and Research Reports Journal Reference count : 32 Volume : 1 Pages : 100048								2020
Is NRG2α Fusion a “Doppelgänger” to NRG1α/β Fusions in Oncology? Authors : Misako Nagasaka , Sai-Hong Ignatius Ou Journal : Journal of Thoracic Oncology Journal Reference count : 21 Volume : 15 Pages : 878-880								2020
An internet-based survey of factors influencing patients’ satisfaction score and factors leading to discontinuation of treatment in lung cancer patients in China. Authors : Weini Qiu , Sai-Hong Ignatius Ou Journal : Journal of Clinical Oncology Volume : 36 Pages : e18871-e18871								2018
ASCEND-5: too little too late? Authors : Fengying Wu , Sai-Hong Ignatius Ou Journal : Journal of Thoracic Disease Volume : 9 Pages : 3477-3479								2017
Further Advances in the Management of Anaplastic Lymphoma Kinase–Mutated Non–Small-Cell Lung Cancer Authors : Sai-Hong Ignatius Ou Journal : Journal of Clinical Oncology Journal Reference count : 36 Volume : 35 Pages : 2463-2466								2017
Laying the Groundwork to Confront the Final Frontier of CNS Metastasis in NSCLC with Targetable Driver Mutations Authors : Thanyanan Reungwetwattana , Sai-Hong Ignatius Ou Journal : Journal of Thoracic Oncology Journal Reference count : 15 Volume : 11 Pages : 281-283								2016
Darkness before dawn, but will the sun always rise? Authors : Sai‐Hong Ignatius Ou Journal : Cancer Journal Reference count : 19 Volume : 121 Pages : 2514-2516								2015
To the Editor Authors : Sai-Hong Ignatius Ou Journal : Journal of Thoracic Oncology Journal Reference count : 2 Volume : 9 Pages : e57-e58								2014
Republished: Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy? Authors : Sai-Hong Ignatius Ou Journal : Postgraduate Medical Journal Journal Reference count : 95 Volume : 90 Pages : 228-235								2014
Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy? Authors : Sai-Hong Ignatius Ou Journal : Journal of Clinical Pathology Journal Reference count : 95 Volume : 66 Pages : 839-846								2013
Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence Authors : Sai-Hong Ignatius Ou Journal : Critical Reviews in Oncology/Hematology Journal Reference count : 117 Volume : 83 Pages : 407-421								2012
Crizotinib: a drug that crystallizes a unique molecular subset of non-small-cell lung cancer Authors : Sai-Hong Ignatius Ou Journal : Expert Review of Anticancer Therapy Journal Reference count : 53 Volume : 12 Pages : 151-162								2012
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond Authors : Sai-Hong Ignatius Ou Journal : Drug Design, Development and Therapy Pages : 471								2011

Research Support Chat

Sai-hong ignatius ou

17 Publications

Home

Indexing Services

Customer Service

Research Support Chat

Advanced search ?

You can also search by the journal's Country or the impact indicator H-index.

Sai-hong ignatius ou

17 Publications

You can also search
by the journal's Country or the impact indicator H-index.